lipoxin a4 has been researched along with cyclic gmp in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, F; He, Q; Huang, CJ; Jin, SW; Li, R; Lian, QQ; Smith, FG; Wang, Q; Wu, DR; Yang, Y; Ying, BY; Zheng, SX; Zheng, X | 1 |
1 other study(ies) available for lipoxin a4 and cyclic gmp
Article | Year |
---|---|
Lipoxin A(4) activates alveolar epithelial sodium channel, Na,K-ATPase, and increases alveolar fluid clearance.
Topics: Acute Lung Injury; Alveolar Epithelial Cells; Animals; Cells, Cultured; Cyclic AMP; Cyclic GMP; Epithelial Sodium Channel Agonists; Epithelial Sodium Channel Blockers; Epithelial Sodium Channels; Gene Expression; Heptanoic Acids; Lipopolysaccharides; Lipoxins; Male; Mucociliary Clearance; Oligopeptides; Peroxidase; Pulmonary Alveoli; Rats; Rats, Sprague-Dawley; Sodium-Potassium-Exchanging ATPase; Tumor Necrosis Factor-alpha | 2013 |